CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102)
CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease: an International Multicenter Study (CHESS2102)
Sponsor: Ehime University Graduate School of Medicine
A observational or N/A phase clinical study on Compensated Advanced Chronic Liver Disease, this trial is ongoing. The trial is conducted by Ehime University Graduate School of Medicine and has accumulated 6 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Aug 2023 — Jul 2024 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
May 2023 — Aug 2023 [monthly]
Not Yet Recruiting
▶ Show 1 earlier version
-
Sep 2021 — May 2023 [monthly]
Not Yet Recruiting
First recorded
Jul 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ehime University Graduate School of Medicine
- Hepatopancreatobiliary Surgery Institute of Gansu Province
- Hyogo Medical University
- Institute of Liver and Biliary Sciences (ILBS)
- Korea University
- LanZhou University
- Ruijin Hospital
- Tianjin Second People's Hospital
- Zagazig University
For direct contact, visit the study record on ClinicalTrials.gov .